Michael Lübbert

15PUBLICATIONS
100CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMolecular targetsHaematological tumoursAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini

|Nov 08, 2025
DNA methyltransferase inhibitors in hematological malignancies and solid tumors.

Valentin Wenger, Guillermo Garcia-Manero, Robert Zeiser

|Apr 04, 2025
Therapeutic targeting of chromatin alterations in leukemia and solid tumors.

Florian Perner, Tobias Berg, Daniel Sasca

|Mar 31, 2025
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Etienne Sollier, Anna Riedel, Umut H Toprak

|Nov 26, 2024
Genocopy of EVI1-AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking.

Julian List, Etienne Sollier, Fiona Brown-Burke

|Sep 24, 2024
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study.

Klaus Geissler, Zdenek Koristek, Teresa Bernal Del Castillo

Pageof 3